Published in Pediatr Endocrinol Rev on September 01, 2010
Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors. Int J Nanomedicine (2014) 0.90
Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review. Radiat Oncol (2012) 0.89
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27
Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med (1996) 5.14
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32
A classification scheme for childhood cancer. Int J Cancer (1987) 4.24
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev (2000) 3.01
Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst (2001) 2.94
Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med (1993) 2.53
Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab (2009) 2.48
Pituitary function after treatment of intracranial tumours in children. Lancet (1975) 2.25
Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab (1998) 2.17
Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer (2003) 2.11
Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol (1985) 1.95
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab (1982) 1.78
Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr (1991) 1.76
Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab (2006) 1.74
Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med (1989) 1.74
Insulin-like growth factor physiology and cancer risk. Eur J Cancer (2000) 1.71
Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med (1989) 1.67
Growth retardation in children after megavoltage irradiation of the spine. Cancer (1973) 1.67
Cranial irradiation and early puberty. J Clin Endocrinol Metab (1994) 1.64
The IGF-I receptor in cancer research. Exp Cell Res (1999) 1.64
Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child (1987) 1.62
Medulloblastoma: clinical and biologic aspects. Neuro Oncol (1999) 1.61
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) (2007) 1.50
Leukaemia in patients treated with growth hormone. Lancet (1988) 1.46
Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab (2002) 1.38
Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther (2003) 1.38
Growth hormone deficiency after treatment of acute leukaemia in children. Arch Dis Child (1976) 1.36
Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol (2008) 1.35
Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet (1987) 1.35
Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am (1984) 1.30
Growth hormone and tumour recurrence. BMJ (1992) 1.30
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. Neuro Oncol (2009) 1.20
Irradiation-induced growth failure. Clin Endocrinol Metab (1986) 1.19
The effects of growth hormone therapy in children with radiation-induced growth hormone deficiency. Acta Paediatr Scand (1981) 1.18
Effect of spinal irradiation on growth. Arch Dis Child (1987) 1.18
Incidence and clinical features of asymptomatic meningiomas. J Neurosurg (2000) 1.16
Childhood brain tumors. J Pediatr Endocrinol Metab (2002) 1.15
Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res (2000) 1.14
Endocrine deficit after fractionated total body irradiation. Arch Dis Child (1992) 1.12
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf) (1999) 1.11
Childhood brain tumors: accomplishments and ongoing challenges. J Child Neurol (2008) 1.11
Radiation therapy for pediatric central nervous system tumors. J Child Neurol (2009) 1.09
Growth impairment in children treated for brain tumours. Arch Dis Child (1978) 1.08
Epidemiologic impact of children with brain tumors. Childs Nerv Syst (1999) 1.08
Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol (1991) 1.07
Hypopituitarism following Radiotherapy Revisited. Endocr Dev (2009) 1.06
Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab (2009) 1.04
Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin Endocrinol Metab (2008) 1.03
Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child (1989) 1.02
Medical and neurocognitive late effects among survivors of childhood central nervous system tumors. Cancer (2001) 1.01
Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr Suppl (1999) 1.01
Precocious puberty after hypothalamic and pituitary irradiation in young children. N Engl J Med (1984) 1.00
Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) (1998) 0.99
Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr (1988) 0.98
Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) (1989) 0.97
Does growth hormone cause relapse of brain tumours? Lancet (1987) 0.97
Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism. Am J Dis Child (1985) 0.97
Central nervous system tumors. Pediatr Clin North Am (2008) 0.97
Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab (1986) 0.96
Sitting height and subischial leg length centile curves for boys and girls from Southeast England. Ann Hum Biol (2002) 0.96
Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer (1999) 0.95
Precocious puberty secondary to cranial irradiation for tumors distant from the hypothalamo-pituitary area. Horm Res (1985) 0.95
Unusual case of double primary orbital tumour. Br J Ophthalmol (1953) 0.94
Growth without growth hormone. J Pediatr Endocrinol Metab (2002) 0.94
A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation. Clin Endocrinol (Oxf) (1992) 0.93
Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol (1997) 0.92
Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr (1986) 0.92
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol (2001) 0.92
Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. Neuro Oncol (2004) 0.91
Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J Clin Endocrinol Metab (1999) 0.91
Growth hormone deficiency in children with brain tumors. Cancer (1976) 0.91
The evolution of spinal growth after irradiation. Clin Oncol (R Coll Radiol) (1991) 0.91
Growth and development in children after bone marrow transplantation. Horm Res (1988) 0.89
Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab (2000) 0.89
Age at treatment and long-term performance results in medulloblastoma. Cancer (1984) 0.89
Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr Scand (1990) 0.89
Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. J Clin Endocrinol Metab (2007) 0.88
Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol (1990) 0.88
Endocrine sequelae in survivors of childhood cancer. Adolesc Med (2002) 0.88
Growth and growth hormone in children after bone marrow transplantation. Horm Res (1988) 0.88
The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J Clin Endocrinol Metab (2003) 0.87
Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child (1991) 0.87
Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med (1991) 0.87
Is growth hormone stimulation testing in children still appropriate? Growth Horm IGF Res (2004) 0.87
Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary (2005) 0.86
Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys (1982) 0.86
Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr (1984) 0.86
The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer (1992) 0.86
Endocrine disorders following treatment of childhood brain tumours. Br J Cancer (1990) 0.86
A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab (1989) 0.86
Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab (1999) 0.86
Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant (1993) 0.85
Risk of leukemia after treatment with pituitary growth hormone. JAMA (1993) 0.85
Hypopituitarism after cranial irradiation. J Endocrinol Invest (2005) 0.85
Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci (2008) 1.41
Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer Res (2004) 1.28
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle (2011) 1.07
Adrenocortical tumors and hyperplasias in childhood--etiology, genetics, clinical presentation and therapy. Pediatr Endocrinol Rev (2006) 0.92
Pathologic lower extremity fractures in children with Alagille syndrome. J Pediatr Gastroenterol Nutr (2010) 0.92
Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features. Am J Med Genet A (2013) 0.87
Alterations in the expression of insulin-like growth factors and their binding proteins in lung cancer. Methods Mol Med (2003) 0.82
Expanded spectrum of recombinant human growth hormone therapy. Curr Opin Pediatr (2002) 0.81
Insulin-Like Growth Factor-I is a Marker for the Nutritional State. Pediatr Endocrinol Rev (2015) 0.81
Non-invasive fluorescence imaging of cell death in fresh human colon epithelia treated with 5-Fluorouracil, CPT-11 and/or TRAIL. Cancer Biol Ther (2005) 0.81
Energy expenditure in obesity associated with craniopharyngioma. Childs Nerv Syst (2010) 0.80
PTU-associated vasculitis in a girl with Turner Syndrome and Graves' disease. Pediatr Emerg Care (2006) 0.79
POTENTIAL NON-GROWTH USES OF rhIGF-I. Growth Genet Horm (2007) 0.78
Long-term linear growth and puberty in pediatric liver transplant recipients. J Pediatr (2013) 0.77
Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A. Growth Horm IGF Res (2007) 0.77
Reconciling diabetes management and the ketogenic diet in a child with pyruvate dehydrogenase deficiency. J Child Neurol (2006) 0.77
Internet informs parents about growth hormone. Horm Res Paediatr (2013) 0.75
Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children. Horm Res Paediatr (2016) 0.75
The Physiology and Mechanism of Growth. World Rev Nutr Diet (2017) 0.75
The Physiology and Mechanism of Growth. World Rev Nutr Diet (2016) 0.75
Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and IGF-I Z-scores. J Clin Res Pediatr Endocrinol (2017) 0.75